A recent study indicates that patients who stop using blockbuster slimming jabs like Wegovy and Mounjaro tend to recover lost weight much more quickly than those who end traditional diet and exercise programs.
Findings released in a leading health publication points out that while obese individuals often shed substantial amounts of their body weight while on the medication, the mass comes back at an estimated rate of nearly a kilo each month once they quit.
"People purchasing these treatments must be aware of the potential of rapid rebound weight gain when the treatment ends," warns researcher Dr. Susan Jebb.
Such speed of regain suggests a return to starting weight in about a year and a half.
Comparing Approaches
The study, which looked at dozens of studies involving thousands of patients, contrasted the outcomes of the injectable medications with other pills.
Scientists point out that people who shed pounds through lifestyle changes alone generally have a less rapid creep back—perhaps 100 grams monthly—after stopping.
Explaining the Fast Rebound
Nutrition scientists believe the way of the injections accounts for the heightened weight return.
The injections mimic a natural hormone called glucagon-like peptide-1, which helps regulate hunger.
"Sustained high doses of the hormone concentrations several times higher than the body's typical production might result in the system to generate a reduced amount of its endogenous GLP-1, and could reduce responsiveness to its effects," noted Dr. Adam Collins, a dietetics specialist.
"Withdrawal of this hormone supplement leads to appetite is unsuppressed, making binge eating much more probable."
A Chronic Issue?
The NHS recommend the injections for individuals with weight-linked health risks, accompanied by prescribed diet and exercise modifications.
Many experts argue that, considering the high risk of relapse, the treatment should be considered long-term.
This opinion is reinforced by pharmaceutical companies, who note that the results "highlight the persistent character of excess weight," similar to managing diseases like hypertension.
User Accounts
People who have come off the jabs describe a intense resurgence of appetite.
"It was like something flipping and you're instantly ravenous," said an individual.
This difficulty is worsened if individuals have not established lasting lifestyle or habit modifications during therapy.
Growing Use
Recent estimates indicate that a significant number of adults in the UK have used these injections in the last 12 months, with desire being substantial.
- Adoption is more common among women compared to males.
- The 40s and 50s demographic shows the highest usage rates.
- A large proportion access the drugs through private healthcare rather than public health services.
In conclusion, clinicians emphasize that while the jabs are effective tools for weight loss, they are not a standalone solution and maintained weight loss relies on combined behavioural support.
